Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson’s Disease
Dengjun Guo, Bing Han, Yu-Qiang Lu, et al.
Parkinson s Disease (2020) Vol. 2020, pp. 1-6
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Narayanappa Amruta, Wesley H. Chastain, Meshi Paz, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 1-15
Open Access | Times Cited: 117
Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression
Cynthia Putri, Timotius Ivan Hariyanto, Joshua Edward Hananto, et al.
Parkinsonism & Related Disorders (2021) Vol. 87, pp. 155-161
Open Access | Times Cited: 55
Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson’s Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture
Keisuke Suzuki, Ayaka Numao, Tomoko Komagamine, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 1047-1056
Open Access | Times Cited: 46
Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1405-1405
Open Access | Times Cited: 36
MALAT1 lncRNA and Parkinson’s Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches
M. Abrishamdar, Maryam Sadat Jalali, M. Rashno
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5253-5262
Closed Access | Times Cited: 30
Barriers to Accessing Healthcare Services for People with Parkinson’s Disease: A Scoping Review
Muhammed Shahriar Zaman, Setareh Ghahari, Mary Ann McColl
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1537-1553
Open Access | Times Cited: 38
Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review
Samantha K. Brooks, Dale Weston, Neil Greenberg
Public Health (2021) Vol. 199, pp. 77-86
Open Access | Times Cited: 36
Impact of the COVID-19 pandemic on physical activity, anxiety, and depression in patients with Parkinson’s disease
Birgül Balcı, Burçin Aktar, Sinan Buran, et al.
International Journal of Rehabilitation Research (2021) Vol. 44, Iss. 2, pp. 173-176
Open Access | Times Cited: 34
The impact of the quarantine period due to the pandemic on the severity of Parkinson's disease and the quality of life of Parkinson's patients
Fatemeh Rafizadeh, Masoud Saadat Fakhr, Elham Davtalab Esmaeili, et al.
Clinics (2025) Vol. 80, pp. 100605-100605
Open Access
COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management
Galit Yogev‐Seligmann, Michal Kafri
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease
Bradley McDaniels, Indu Subramanian
International review of neurobiology (2022), pp. 197-227
Open Access | Times Cited: 17
The COVID-19 pandemic impacts all domains of quality of life in Egyptians with spinal cord injury: a retrospective longitudinal study
Abdelrahman Elaraby, Mostafa Shahein, Amira Hassan Bekhet, et al.
Spinal Cord (2022) Vol. 60, Iss. 8, pp. 757-762
Open Access | Times Cited: 16
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic
Silvia Giusiano, Laura Peotta, Barbara Iazzolino, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2021) Vol. 23, Iss. 1-2, pp. 146-148
Closed Access | Times Cited: 23
Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?
Lisanne J. Dommershuijsen, Anouk van der Heide, Eija Berg, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Exacerbation of Pre-existing Neurological Symptoms With COVID-19 in Patients With Chronic Neurological Diseases: An Updated Systematic Review
Md Sakibuzzaman, Anid Hassan, Samira Hayee, et al.
Cureus (2022)
Open Access | Times Cited: 13
The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson’s Disease: An Updated Systematic Review
Vikash Jaiswal, Danah Alquraish, Zouina Sarfraz, et al.
Journal of Primary Care & Community Health (2021) Vol. 12
Open Access | Times Cited: 17
Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience
Aurélie de Rus Jacquet, Sarah Bogard, Catherine P. Normandeau, et al.
Parkinsonism & Related Disorders (2021) Vol. 91, pp. 66-76
Open Access | Times Cited: 17
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics
К. Ray Chaudhuri, Katarina Rukavina, Victor McConvey, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 6, pp. 615-623
Open Access | Times Cited: 16
Cyberchondria severity and quality of life among Lebanese adults: the mediating role of fear of COVID-19, depression, anxiety, stress and obsessive–compulsive behavior—a structural equation model approach
Clara Rahme, Marwan Akel, Sahar Obeïd, et al.
BMC Psychology (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Impact of COVID-19 on Health Seeking Behavior of Patients with Chronic Disease at Public Hospitals in Jimma Zone, South West Ethiopia
Samira Awel, Ismael Ahmed, Desalew Tilahun Beyene, et al.
Risk Management and Healthcare Policy (2022) Vol. Volume 15, pp. 1491-1500
Open Access | Times Cited: 12
COVID-19 related neurological manifestations in Parkinson’s disease: has ferroptosis been a suspect?
Fengju Jia, Jing Han
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Parkinson's disease patients' needs during the COVID‐19 pandemic in a red zone: A framework analysis of open‐ended survey questions
Francesco Cavallieri, Francesca Sireci, Valentina Fioravanti, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3254-3262
Open Access | Times Cited: 15
Differential Impact of the COVID-19 Pandemic on Health Care Utilization Disruption for Community-Dwelling Individuals With and Without Acquired Brain Injury
Grace Kim, Hayejin Kim, Jason Fletcher, et al.
Archives of Rehabilitation Research and Clinical Translation (2021) Vol. 4, Iss. 1, pp. 100176-100176
Open Access | Times Cited: 15
Effect of COVID-19 home confinement on sleep monitorization and cardiac autonomic function in people with multiple sclerosis: A prospective cohort study✰,✰✰
Luis Andreu‐Caravaca, Domingo Jesús Ramos‐Campo, Pedro Manonelles, et al.
Physiology & Behavior (2021) Vol. 237, pp. 113392-113392
Open Access | Times Cited: 13
Secondary Impact of COVID-19 Pandemic on People with Parkinson’s Disease—Results of a Polish Online Survey
Karolina Krzysztoń, Beata Mielańczuk-Lubecka, Jakub Stolarski, et al.
Brain Sciences (2021) Vol. 12, Iss. 1, pp. 26-26
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top